World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
43625
World Ranking
9526
National Ranking
4910

Overview

Edward Gabrielson is affiliated with the Johns Hopkins University School of Medicine in the United States. Their primary research focus spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions particularly in Oncology, Molecular Biology, and Cancer Research. Additional subfields of focus include Pulmonary and Respiratory Medicine as well as Radiology, Nuclear Medicine and Imaging.

Their research covers several main topics, highlighting areas such as Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations, and Cancer Genomics and Diagnostics. They also work on Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, and the interplay between Cancer, Hypoxia, and Metabolism.

Among the recent notable publications authored by Edward Gabrielson are:

  • NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes, 2020, Clinical Cancer Research
  • Association between pathologic response and survival after neoadjuvant therapy in lung cancer, 2023, Nature Medicine
  • Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cells, 2022, Cell Death and Disease
  • Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics, 2021, Proceedings of the National Academy of Sciences
  • DNA methylation markers predict recurrence-free interval in triple-negative breast cancer, 2020, npj Breast Cancer

Frequent coauthors collaborating with Edward Gabrielson include:

  • Akhilesh Mishra
  • Sridhar Nimmagadda
  • Ashley Cimino-Mathews
  • Patrick M. Forde
  • Dhiraj Kumar

Preferred publication venues for their research comprise Cancer Research, Clinical Cancer Research, Oncogene, Nature Medicine, and Cell Death and Disease.

Best Publications

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

    Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger

  • 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

    Adrian Merlo;James G. Herman;Li Mao;Daniel J. Lee

  • Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

    Patrick M. Forde;Jamie E. Chaft;Kellie N. Smith;Valsamo Anagnostou

  • Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors

    Manel Esteller;Jose Maria Silva;Gemma Dominguez;Felix Bonilla

  • Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

    Steven A. Belinsky;Kristen J. Nikula;William A. Palmisano;Ruth Michels

  • Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.

    Anju Singh;Vikas Misra;Rajesh K Thimmulappa;Hannah Lee

  • Multiple-laboratory comparison of microarray platforms

    Rafael A Irizarry;Daniel Warren;Forrest Spencer;Irene F Kim

  • A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

    Hiromu Suzuki;Edward Gabrielson;Edward Gabrielson;Wei Chen;Wei Chen;Ramaswamy Anbazhagan;Ramaswamy Anbazhagan

  • Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program

    Kevin J. Cheung;Edward Gabrielson;Zena Werb;Andrew J. Ewald

  • Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

    P. Cairns;T. J. Polascik;Y. Eby;K. Tokino

  • Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

    Valsamo Anagnostou;Kellie N. Smith;Patrick M. Forde;Noushin Niknafs

  • DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer

    Malcolm V. Brock;Craig M. Hooker;Emi Ota-Machida;Yu Han

  • Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.

    Lais Osmani;Frederic Askin;Edward Gabrielson;Qing Kay Li

  • Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.

    Christopher M. Heaphy;Andrea P. Subhawong;Seung Mo Hong;Michael G. Goggins

  • Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression

    Jeremy R. Graff;Edward Gabrielson;Hiraoki Fujii;Stephen B. Baylin

  • Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors

    Anju Singh;Sreedhar Venkannagari;Kyu H. Oh;Ya Qin Zhang

  • Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

    Livia Casciola-Rosen;Kanneboyina Nagaraju;Paul Plotz;Kondi Wang

  • Inactivation of Glutathione S-Transferase P1 Gene by Promoter Hypermethylation in Human Neoplasia

    Manel Esteller;Paul G. Corn;Jesus M. Urena;Edward Gabrielson

  • High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung Cancer

    Roy M. Bremnes;R. Veve;E. Gabrielson;F. R. Hirsch

  • Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis (p16 methylationysputumyNNKysquamous cell carcinoma)

    Steven A. Belinsky;K Risten J. Nikula;William A. Palmisano;Ruth Michels

Frequent Co-Authors

Stephen B. Baylin
Stephen B. Baylin Johns Hopkins University
James G. Herman
James G. Herman University of Pittsburgh
Saraswati Sukumar
Saraswati Sukumar Johns Hopkins University School of Medicine
Julie R. Brahmer
Julie R. Brahmer Johns Hopkins University
Hui Zhang
Hui Zhang Johns Hopkins University
Vered Stearns
Vered Stearns Johns Hopkins University
Shyam Biswal
Shyam Biswal Johns Hopkins University
David Sidransky
David Sidransky Johns Hopkins University School of Medicine
Curtis C. Harris
Curtis C. Harris National Institutes of Health
Matthew D. Hellmann
Matthew D. Hellmann Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in careers related to medicine, a range of online degrees and pathways offer flexibility and affordability. Beyond an MD, health professionals can find accelerated options and specialized programs online that cater to diverse interests.

If you're interested in mental health and wish to serve as a nurse practitioner, consider the fastest pmhnp program options available online. These programs can help you quickly gain advanced credentials in psychiatric care.

For those with an interest in healthcare leadership or hospital management, an online health management degree could open doors to administrative roles. Comprehensive training in healthcare policy, planning, and leadership is also accessible through online mha programs affordable for various budgets.

If your goal is advanced clinical practice or leadership, consider a Doctor of Nursing Practice (DNP). Explore the best online dnp programs for a flexible pathway to the highest level of nursing practice.

Best Scientists Citing Edward Gabrielson

Trending Scientists

Recently Published Articles